Nabumetone
Product Images NDC 16590-160

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 16590-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nabumetone 750mg Label Image (Nabumetone 750mg)

Packaging label for Nabumetone 750 mg tablets by STAT RX USA LLC, containing 30 tablets. It is labeled as generic for Relafen, with NDC 16590-160-30. The label includes manufacturing information by Par Pharmaceutical Co., Inc., and warnings about potential drowsiness or dizziness.*

FDA Label Image

This Is The Graph (Graph1)

A pharmacokinetic concentration-time profile graph showing nabumetone plasma concentrations (ng/mL) over 70 hours for doses of 1000 mg and 2000 mg per day. The graph includes shaded areas representing ±2 standard deviations for each dose group over the time course.*

FDA Label Image

This Is The Chemical Structure. (Structure1)

Chemical structure of nabumetone showing the molecular arrangement including aromatic rings, a methoxy group, and a ketone functional group.*

FDA Label Image

This Is The Chemical Structure (Structure2)

Chemical structure diagram of nabumetone, showing a bicyclic aromatic ring with a methoxy group and a carboxylic acid functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.